Glycomimetics Inc

Ownership Transactions Reported by 31 Insiders

Symbol
GLYC on Nasdaq
Industry
Pharmaceutical Preparations
Location
9708 Medical Center Drive, Rockville, MD

There are no Buy or Sell transactions made by insiders since 11/24/2024

Glycomimetics Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Scott D. Sandell 10%+ Owner $5.28M Jan 25, 2023
Siren, L.L.C. 10%+ Owner $2.29M Jul 25, 2024
Rachel King Director $1.55M May 1, 2024
Invus Public Equities, L.P. 10%+ Owner $1.21M Aug 7, 2024
John L. Magnani SVP of Research, CSO $875K Nov 11, 2022
Chinmaya Rath SVP and Chief Business Officer $380K Jan 12, 2024
Fairmount Funds Management LLC Director, 10%+ Owner $347K Jun 23, 2025
Bruce S. Johnson SVP & Chief Commercial Officer $328K Jan 12, 2024
Junius Daniel M Director $295K May 1, 2024
Edwin Rock Chief Medical Officer $182K Jun 20, 2024
Patricia S. Andrews Director $138K May 1, 2024
Mark Alan Goldberg Director $109K May 1, 2024
Scott Koenig Director $86.7K May 1, 2024
Armand Girard SVP, Chief Business Officer $68.8K Nov 11, 2022
Joshua T. Brumm Chief Executive Officer, Director $67.1K Jun 13, 2025
Jonathan McNeill Chief Operating Officer and President. Exhibit 24 - Power of Attorney $33.6K Jun 13, 2025
Brian M. Hahn SVP Finance, CFO $17.5K Jun 18, 2024
Jonathan Violin Director $17.4K Jun 23, 2025
Bvf Partners L P/Il 10%+ Owner $15.6K Jun 13, 2025
Christopher Doughty Chief Business Officer $9.87K Jun 13, 2025
Barbara Bispham General Counsel and Corporate Secretary. Exhibit 24 - Power of Attorney Jun 13, 2025
Ellie Im Chief Medical Officer Jun 13, 2025
Jan Pinkas Chief Scientific Officer Jul 16, 2025
Susan Moran Director Jun 23, 2025
Alexandra Balcom Director Jun 23, 2025
David Lubner Director Jun 23, 2025
Richard William Scalzo Chief Financial Officer Jun 13, 2025
Ryan Lynch Treasurer, Senior Vice President of Finance and Chief Accounting Officer. Exhibit 24 - Power of Attorney Jun 13, 2025
Harout Semerjian Chief Executive Officer, Director Jan 12, 2024
Timothy R. Pearson Director May 1, 2024
Scott Thomas Jackson Director May 1, 2024

Recent Insider Transactions by Companies or Individuals for Glycomimetics Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.